A randomized phase II study of pemetrexed in combination with cisplatin or carboplatin as first-line therapy for patients with locally advanced or metastatic non-small-cell lung cancer - Schuette, WHW; Gröschel, A; Sebastian, M (Clin Lung Cancer, 2013)
et al.